以第一作者或通讯作者发表SCI论文10余篇，参与撰写国内指南或专家共识4篇，已发表2篇。
1. Ma J*, Liu X*, Qiao L, Meng L, Xu X, Xue F, Cheng C, Han Z, Lu Y, Zhang W, Bu P, Zhang M, An G, Lu H, Ni M, Zhang C, Zhang Y. Association Between Stent Implantation and Progression of Nontarget Lesions in a Rabbit Model of Atherosclerosis. Circ Cardiovasc Interv. 2021 Nov;14(11):e010764.（并列第一作者）
2. Liu X*, Ma J*, Ma L, Liu F, Zhang C, Zhang Y, Ni M. Overexpression of tissue factor induced atherothrombosis in apolipoprotein E-/- mice via both enhanced plaque thrombogenicity and plaque instability. J Mol Cell Cardiol. 2019;127:1‐10.
3. Ma J, Qiao L, Meng L, Ma L, Zhao Y, Liu XL*, Ni M*, Zhang Y. Tongxinluo may stabilize atherosclerotic plaque via multiple mechanisms scanning by genechip. Biomed Pharmacother. 2019;113:108767.（共同通讯）
4. Xu P, Cao Y, Zhang S, Liu X*, Zhang M*, Zhang C*. The predictive value of serum Dickkopf-1, Dickkopf-3 level to coronary artery disease and acute coronary syndrome. Int J Cardiol. 2024;403:131887. （共同通讯）
5. Liu XL*, Ni M*, Ma L*, Yang J, Wang L, Liu F, Dong M, Yang X, Zhang M, Lu H, Wang J, Zhang C, Jiang F, Zhang Y. Targeting blood thrombogenicity precipitates atherothrombotic events in a mouse model of plaque destabilization. Sci Rep. 2015;5:10225.
6. Liu XL, Zhang PF, Ding SF, Wang Y, Zhang M, Zhao YX, Ni M, Zhang Y. Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice. PLoS One. 2012;7(3):e33497.
7. Ding SF*, Ni M*, Liu XL*, Qi LH, Zhang M, Liu CX, Wang Y, Lv HX, Zhang Y. A causal relationship between shear stress and atherosclerotic lesions in apolipoprotein E knockout mice assessed by ultrasound biomicroscopy. Am J Physiol Heart Circ Physiol, 2010;298(6):H2121-2129.（并列第一作者）
8. Ma L, Ni M, Hao P, Lu H, Yang X, Xu X, Zhang C, Huang S, Zhao Y, Liu XL*, Zhang Y*. Tongxinluo mitigates atherogenesis by regulating angiogenic factors and inhibiting vasa vasorum neovascularization in apolipoprotein E-deficient mice, Oncotarget, 2016;7(13):16194-16204.(共同通讯作者)
9. Zhang M, Liu Y, Xu M, Zhang L, Liu Y, Liu X, Zhao Y, Zhu F, Xu R, Ou Z, Wang Y, Liu Q, Ma S, Wang T, He M, Lu Q, Li H, Huang J, Zhang Y. Carotid artery plaque intervention with Tongxinluo capsule (CAPITAL): A multicenter randomized double-blind parallel-group placebo-controlled study. Sci Rep. 2019 Mar 14;9(1):4545.
10. Zhang K, Liu X, Yu Y, Luo T, Wang L, Ge C, Liu X, Song J, Jiang X, Zhang Y, Qin S, Zhang M. Phospholipid transfer protein destabilizes mouse atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2537-44. doi: 10.1161/ATVBAHA.114.303966. Epub 2014 Oct 16. Erratum in: Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):e2.
11. 沈赞,邵志敏,中华医学会肿瘤学分会肿瘤支持康复治疗学组等.中国乳腺癌相关心脏病诊疗共识（2022年版）[J].中国癌症杂志,2022,32(10):1016-1036.DOI:10.19401/j.cnki.1007-3639.2022.10.010.
12. 中国抗癌协会整合肿瘤心脏病学分会, 中华医学会超声医学分会, 中国超声心动图学会. 无创性影像学技术评估肿瘤治疗相关心血管毒性的临床应用指南（2023版） [J] . 中华医学杂志, 2023, 103(42) : 3367-3383. DOI: 10.3760/cma.j.cn112137-20230908-00428.
1. 作为项目负责人承担国家自然科学基金2项：
（1）凝血酶通过PAR1介导对斑块稳定性的影响及其作用机制的研究。 国家自然科学基金青年基金，No. 81300217，2014.1-2016.12，项目负责人。
（2）SAA/CRP介导的急性时相反应激活在支架置入术后非罪犯病变进展中的作用和力学机制研究 ，国家自然科学基金面上项目，No. 82070453，2021.1-2024.12，项目负责人。
2. 作为骨干参与临床研究4项
（1）超声心动图评估乳腺癌化疗及靶向治疗心脏毒性的真实世界多中心研究
（2）西红花总苷片对乳腺癌放化疗患者心血管功能保护作用的临床研究Protection of Cardiovascular Function with Crocin in BrEast Cancer patients undergoing Radiotherapy and Chemotherapy （ProtECtion Study）
（3）应用通心络胶囊干预颈动脉斑块的多中心随机双盲安慰剂平行对照研究（CAPITAL研究）
（4）复方丹参滴丸对冠状动脉微血管性心绞痛冠脉血流储备作用的临床研究Microvascular Angina Intervention with Compound Dan-Shen Root Dropping Dill（MAIDS）
